Print pageEmail pageRSS Feeds

We are building a strong, well-run business, structured to deliver sustainable results over the long term.

Along with biotechnology leadership, the ARIAD team is focused on its commitment to deliver long-term value to investors through solid business execution. That means maintaining disciplined cost control, thoughtful capital deployment and the highest standards of corporate governance.

Webcast ImageWebcast - Replay
Q2 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
08/06/14 at 8:30 a.m. ET
Q2 2014 ARIAD Pharmaceuticals, Inc. Earnings Conference Call
Wednesday, August 6, 2014 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Recent Press Releases
More >>
08/06/14
ARIAD Reports Second Quarter 2014 Financial Results and Development Progress
08/05/14
ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Israel
Investor Downloads

Download Documentation Corporate Presentation
More >>

ARIAD Stock Price: $5.98

Stock Symbol: ARIA

Stock Exchange: NASDAQ

Stock Quote at: 08/19/14

4:00 p.m. ET
(US Dollar)
CHANGE (%) Stock is Up 0.04 (0.67%)
VOL4,489,100
OPEN$5.96
PREV. CLOSE$5.94
DAY HIGH$6.02
DAY LOW$5.87
52 WK. HIGH$23.00
Minimum 20 minute delay
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.

You are now leaving this website. If you would like to continue, click Continue.
CancelContinue